Financials
Financial year 2025
SOCIETE SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES from Namur, company number BE0506817674, closed financial year 2025 with a result of € 207,586 after tax. For that financial year SOCIETE SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES recorded a gross margin of € 742,435 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 161,128 to € 207,586. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 1.1 million
▲ 22% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 207,586
▲ 29% vs 2024
Profit after tax over the fiscal year.
€ 317,960
▼ 37% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 525,832.
People and assets in 2025
2.9
▲ 0.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 238,049
▲ 34% vs 2024
€ 82,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 7,461
▲ 55% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 112,549
▼ 37% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 80,481
▲ 10% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 245,585 | € 381,274 | € 423,379 | € 742,435 | ▲ 75% |
| Profit after taxes | € 5,197 | € 99,511 | € 161,128 | € 207,586 | ▲ 29% |
| Equity | € 648,261 | € 747,772 | € 903,331 | € 1,103,332 | ▲ 22% |
| Total debts | € 250,255 | € 232,969 | € 308,697 | € 253,429 | ▼ 18% |
| Cash | € 419,341 | € 546,633 | € 502,741 | € 317,960 | ▼ 37% |
| Retained profit | € 70,761 | € 170,272 | € 325,831 | € 525,832 | ▲ 61% |
| Balance sheet total | € 898,515 | € 980,741 | € 1,212,028 | € 1,500,094 | ▲ 24% |
| Employees (FTE) | - | - | 2.5 | 2.9 | ▲ 0.4 |
Key figures of SOCIETE SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to SOCIETE SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES?
What happened at SOCIETE SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 207,586 (▲ 29% vs 2024). Source: NBB ↗
- New establishment in Namur. KBO
- Start of the company according to the CBE. KBO
In short
From € 5,197 profit in 2022 to € 207,586 profit in 2025.
Paid € 204,520 in corporate taxes since 2022.
Best year ever: 2025, with € 207,586 profit.
On average € 256,000 of value added per employee in 2025.
A new publication or filing at SOCIETE SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES? We notify you, reason included.
Follow SOCIETE SCIENTIFIQUE DES PHARMACIENS FRANCOPHONESDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind SOCIETE SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES are Alain Chaspierre and ASSOCIATION SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES. ASSOCIATION SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES is also behind Mdeon.
Directors
According to the 2025 annual accounts
Alain Chaspierre
Personne chargée de la gestion journalière
ASSOCIATION SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES
Président de l'Organe d'Administration · represented by Arnaud Nicolas, Hugues Lambion
Also active at: Mdeon
Establishments
Establishment units
Physical locations of this company
Rue des Dames Blanches 1
5000 Namur
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
All companies at this address →Association des Pharmaciens de Namur et de Luxembourg
€ 1.1 million gross margin · 2025
ASSOCIATION SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES same network
Fidulife - CFG
€ 640,792 gross margin · 2025
ASSOCIATION DES UNIONS DE PHARMACIENS
OFFIMED
€ 966,752 gross margin · 2025
+2 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
MAEHDROS-AS, BE
Website info
Features
Security
Details
- Company number
- 0506.817.674
- VAT number
- BE 0506.817.674
- Registered office
- Rue des Dames Blanches 1, 5000 Namur
- Names & denominations
- SOCIETE SCIENTIFIQUE DES PHARMACIENS FRANCOPHONES · S.S.P.F.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 December 2014
- Peppol
- Active · Active since 18 Sept 2025
- Contact
- sspf.be [email protected]
- Activities · NACE
Beroepsopleiding
Overige vormen van onderwijs
Overige zakelijke dienstverlening, neg